Fetal Congenital Heart Block Associated With Maternal Primary Systemic Lupus Erythematosus and Sjogren's Syndrome

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Oct 21

PMID 34671524

Authors

Sameera Khan

Priyanka Anvekar

Petras Lohana

Mohammed Sheeraz Alam

Syed R Ali

Affiliations

Soon will be listed here.

Abstract

Congenital heart block is a grave condition reported in 0.5% of 100 live births. Systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS) are chronic autoimmune and inflammatory condition, which affects multiple systems. The association of SLE and SS with pregnancy has been seen in the past. Usually, it shows anti-Ro/SSA and anti-Ro/SSB auto-antibodies in maternal serum, which is proportional to fetal Outcome. In this report, we present a case of a 29-year-old female gravida 4, para one and aborta 3, with a history of polycystic ovarian disease and multiple abortions. At 20 weeks of gestation, her antenatal examination revealed fetal bradycardia and heart block, which further led to SLE and SS diagnosis in her. She was treated with steroids to prevent further fetal complications. The patient delivered a healthy neonate at 38 weeks of gestation. The neonate eventually received a cardiac pacemaker and is now on regular follow-up.

References

Friedman D, Kim M, Copel J, Davis C, Phoon C, Glickstein J . Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation. 2008; 117(4):485-93. DOI: 10.1161/CIRCULATIONAHA.107.707661. View

Tseng C, Buyon J . Neonatal lupus syndromes. Rheum Dis Clin North Am. 1997; 23(1):31-54. DOI: 10.1016/s0889-857x(05)70313-6. View

Glatz A, Gaynor J, Rhodes L, Rychik J, Tanel R, Vetter V . Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg. 2008; 136(3):767-73. DOI: 10.1016/j.jtcvs.2008.04.019. View

Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P . Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis. 2003; 62(10):1010-2. PMC: 1754319. DOI: 10.1136/ard.62.10.1010. View

Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette J . Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther. 2005; 7(2):69-73. PMC: 1065339. DOI: 10.1186/ar1690. View

Upala S, Yong W, Sanguankeo A . Association between primary Sjögren's syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol. 2016; 35(8):1949-1955. DOI: 10.1007/s10067-016-3323-9. View

Pisetsky D, Lipsky P . New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020; 16(10):565-579. PMC: 8456518. DOI: 10.1038/s41584-020-0480-7. View

Gupta S, Gupta N . Sjögren Syndrome and Pregnancy: A Literature Review. Perm J. 2017; 21:16-047. PMC: 5267941. DOI: 10.7812/TPP/16-047. View

Dalal D, Patel K, Patel M . Systemic Lupus Erythematosus and Pregnancy: A Brief Review. J Obstet Gynaecol India. 2019; 69(2):104-109. PMC: 6430271. DOI: 10.1007/s13224-019-01212-8. View

10.

Tasdemir M, Hasan C, Agbas A, Kasapcopur O, Canpolat N, Sever L . Sjögren's syndrome associated with systemic lupus erythematosus. Turk Pediatri Ars. 2016; 51(3):166-168. PMC: 5047367. DOI: 10.5152/TurkPediatriArs.2016.2001. View

11.

Warren J, Silver R . Autoimmune disease in pregnancy: systemic lupus erythematosus and antiphospholipid syndrome. Obstet Gynecol Clin North Am. 2004; 31(2):345-72, vi-vii. DOI: 10.1016/j.ogc.2004.03.007. View

12.

Claus R, Hickstein H, Kulz T, Lenschow U, Meiske D, Kotitschke A . Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen. Rheumatol Int. 2006; 26(10):886-95. DOI: 10.1007/s00296-005-0101-4. View

13.

Breur J, Visser G, Kruize A, Stoutenbeek P, Meijboom E . Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol. 2004; 24(4):467-72. DOI: 10.1002/uog.1713. View

14.

Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, Piette J . Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus. 2005; 14(9):660-4. DOI: 10.1191/0961203305lu2195oa. View